Stocklytics Platform
Asset logo for symbol NNVC
NanoViricides
NNVC48
$1.75arrow_drop_up14.18%$0.20
Penny Stock
Asset logo for symbol NNVC
NNVC48

$1.75

arrow_drop_up14.18%

Performance History

Chart placeholder
Key Stats
Open$1.48
Prev. Close$1.48
EPS-0.70
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$20.48M
PE Ratio-
LOWHIGH
Day Range1.43
1.75
52 Week Range1.00
3.59
Ratios
Revenue-
EBITDA Margin %-
EPS-0.70

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About NanoViricides (NNVC)

NanoViricides Inc (NNVC) is a company that specializes in the development of nanomedicines against viral infections. The company's primary focus is on creating novel therapeutics that can target and destroy a wide range of viruses. NanoViricides utilizes a unique platform technology called nanoviricides, which allows for the design and production of nanoscale drug candidates that can mimic the shape and structure of the virus they are targeting. This approach offers several advantages over traditional antiviral drugs, including increased efficacy, broad-spectrum activity, and improved safety profiles.
One of the key advantages of NanoViricides' nanoviricides platform is its ability to rapidly develop therapeutics for emerging and existing viral threats. The company has already demonstrated successful results in preclinical studies against a variety of viruses, including influenza, Ebola, dengue fever, and HIV. These positive outcomes have led to collaborations with government agencies and research organizations, further validating NanoViricides' technology and potential.
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Anil R. Diwan Ph.D.
Headquarters
Shelton
Employees
17
Exchange
NYSE
add NanoViricides  to watchlist

Keep an eye on NanoViricides

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is NanoViricides 's (NNVC) price per share?

The current price per share for NanoViricides (NNVC) is $1.75. The stock has seen a price change of $0.21 recently, indicating a 14.18% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for NanoViricides (NNVC)?

For NanoViricides (NNVC), the 52-week high is $3.59, which is 104.68% from the current price. The 52-week low is $1, the current price is 75.4% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is NanoViricides (NNVC) a growth stock?

NanoViricides (NNVC) has shown an average price growth of -1.65% over the past three years. It has received a score of 29 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying NanoViricides as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is NanoViricides (NNVC) stock price performance year to date (YTD)?

As of the latest data, NanoViricides (NNVC) has a year-to-date price change of 22.66%. Over the past month, the stock has experienced a price change of 30.9%. Over the last three months, the change has been 23.52%. Over the past six months, the figure is 30.9%. Looking at a longer horizon, the five-year price change stands at -76.83%.
help

Is NanoViricides (NNVC) a profitable company?

NanoViricides (NNVC) has a net income of -$8.29M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$8.52M. Furthermore, the EBITDA is -$8.75M.
help

What is the market capitalization of NanoViricides (NNVC)?

NanoViricides (NNVC) has a market capitalization of $20.49M. The average daily trading volume is 1.61, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level